Expertise in
2
conditions

Jan-dirk D. Raguse

Fachklinik Hornheide
Muenster, NW, DE 
Expertise in
2
conditions
Fachklinik Hornheide
Muenster, NW, DE 

Overview

Jan-dirk Raguse practices practicing medicine in Muenster, Germany.

Raguse is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Oral Squamous Cell Carcinoma, Merkel Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Epidermoid Cyst, and Bone Graft.

They are actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 1 clinical trial.

Locations

Fachklinik Hornheide
Muenster, NW, Germany
Other Locations
Berlin, BE 13353, Germany
Stuttgart, BW, Germany
Germany
Kiefer, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized Phase II Study of Two Different Regimens of TPF Induction Chemotherapy Regimen Followed by Radiation Therapy Plus Cetuximab (TPF-CET-HART) vs. HART and Cis-platinum, 5-FU (PF-HART) in Patients With Locally Advanced Unresectable Squamous Cell Carcinomas of the Head and Neck
Randomized Phase II Study of Two Different Regimens of TPF Induction Chemotherapy Regimen Followed by Radiation Therapy Plus Cetuximab (TPF-CET-HART) vs. HART and Cis-platinum, 5-FU (PF-HART) in Patients With Locally Advanced Unresectable Squamous Cell Carcinomas of the Head and Neck
Enrollment Status: Completed
Publish Date: January 31, 2019
Intervention Type: Drug, Radiation
Study Phase: Phase 2

63 Total Publications

Sustained response to rituximab in an ANCA-negative necrotizing vasculitis with initial detection of Corynebacterium kroppenstedtii.
Sustained response to rituximab in an ANCA-negative necrotizing vasculitis with initial detection of Corynebacterium kroppenstedtii.
Journal: Clinical & translational immunology
Published: April 01, 2026

Frequently Asked Questions about Jan-dirk D. Raguse

Is Jan-dirk D. Raguse a top-rated expert for Oral Squamous Cell Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Jan-dirk D. Raguse is classified as an Advanced expert for Oral Squamous Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jan-dirk D. Raguse participate in research or clinical trials?

Yes. Jan-dirk D. Raguse has published 63 articles and abstracts on conditions like Oral Squamous Cell Carcinoma. You can view a list of Jan-dirk D. Raguse's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Raguse's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile